Miniaturized biosensors can enable the toxicology projects to undertake their assays with high throughput and potentially with greater sensitivity. The Biosensor project aims to implement those bio assays that have been developed in the toxicology projects into usable biosensors. The project will have a fundamental aspect, and an applied aspect in which we intend to implement these assays. The fundamental aspects will investigate new nano scale materials for bio labeling, particularly with application to immunoassays. Long lifetime nano scale phosphors have been found to be particularly useful for labeling haptens, analytes, or antibodies in an immunoassay. We will focus on the use of the lanthanide elements, in particular europium, and also other wavelengths that can be offered by the use of materials such as terbium oxide. We shall also investigate a novel format for carrying out immunoassays in a micro droplet. Samples that contain pico liters can be interrogated for very long times with our photobleaching labels, with the potential for approaching single molecule detection limits in assays. The more practical aspect of the project will be concerned with implementing existing assays in miniaturized biosensors on a chip. We shall make use of micro fabrication techniques to make micro channels on a chip in which we shall carry out the immunoassays. We shall make use of indium tin oxide (ITO) films as waveguides and as electrodes to manipulate nanoparticles labels and antibodies in channels. We shall use evanescent detection of the particle labels within the channel, and use an electrostatic field to enhance binding to antibodies, and potentially to regenerate antibodies within the channel. We shall also attempt to improve the detection of DNA for sampling in soils. This will assist Project 1 in undertaking their measurements of toxin-consuming bacteria within soils. The Biosensor project will implement an in vitro assay for dioxin for use in Dr. Denison's project and will work with Dr. Lasley's project to implement a miniaturized, portable biosensor for markers of reproductive health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-21
Application #
7391800
Study Section
Special Emphasis Panel (ZES1)
Project Start
Project End
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
21
Fiscal Year
2007
Total Cost
$207,856
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications